SCHEMBL5635183

SCHEMBL5635183

CC(=O)c1ccc2[nH]c3c(c2c1)CCN(C(C)=O)C31CCN(CCOc2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.47
OGFRL1 Q5TC84 2/20 0.47
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KCNA5 P22460 3/20 0.37
CFTR P13569 1/20 0.37
DRD2 P14416 5/20 0.36
DRD3 P35462 2/20 0.36
LTA4H P09960 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
OPRL1 P41146 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
IDE P14735 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5635098 0.95 OPRM1 (0.44) OPRM1OGFRL1KDM4EALDH1A1KCNA5
SCHEMBL6496428 0.90 CFTR (0.47) OPRM1OGFRL1KDM4ECFTRDRD2
SCHEMBL5635195 0.90 OPRM1 (0.38) OPRM1OGFRL1KDM4EALDH1A1KCNA5
Trifluoroacetic Acid SCHEMBL5634977 0.87 OPRM1 (0.36) OPRM1OGFRL1KDM4EALDH1A1KCNA5
SCHEMBL6278936 0.85 DRD2 (0.46) OPRM1OGFRL1CFTRDRD2DRD3
SCHEMBL6496683 0.84 CFTR (0.46) OPRM1OGFRL1KDM4ECFTRDRD2
SCHEMBL6280476 0.83 CFTR (0.47) KDM4ECFTRDRD2DRD3MEN1
SCHEMBL6280446 0.83 CFTR (0.47) OPRM1OGFRL1CFTR
SCHEMBL5634673 0.83 CFTR (0.52) CFTRKMT2A
SCHEMBL6003860 0.83 CFTR (0.52) CFTRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070004765-A1 New compounds BIOVITRUM AB (SE) 2007-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004765-A1 New compounds GHSR, GIPR, PRLHR OPRM1 1267/4885OGFRL1 373/4885KDM4E 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.